...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.
【24h】

Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.

机译:经卵圆形未闭孔经皮闭合后残余分流患者植入第二个闭合装置。

获取原文
获取原文并翻译 | 示例

摘要

Percutaneous closure of patent foramen ovale (PFO) in patients with presumed paradoxical embolism yields complete occlusion in > 90% of patients using contemporary closure devices. Patients with a residual shunt after percutaneous PFO closure have been found at increased risk for recurrent paradoxical events. Treatment options for such patients include medical treatment using antiplatelet drugs or oral anticoagulation, surgical device removal and patch closure, and percutaneous implantation of a second closure device. We report our experience with implantation of a second closure device in 10 patients with more than a minimal residual shunt
机译:假定存在悖论性栓塞的患者经皮闭合卵圆孔未闭(PFO)可使用现代闭合装置在> 90%的患者中完全闭塞。经皮PFO闭合后残余分流的患者被发现复发矛盾事件的风险增加。此类患者的治疗选择包括使用抗血小板药物或口服抗凝药物进行的医学治疗,手术器械的拆除和贴片闭合以及第二个闭合器械的经皮植入。我们报告了我们的经验,即在经皮PFO闭合后6个月内,残留最小分流超过10例的10例患者中植入了第二个闭合装置。初始和重复干预的程序和透视时间相似(分别为32 vs. 30 min和5 vs. 6 min; P = NS)。第二个闭合装置的植入过程中没有手术并发症。第二次经皮介入治疗后6个月的经食道超声心动图检查发现9例(90%)患者的PFO完全闭合。因此,在经皮PFO闭合后,如果持久性大于残余分流的患者植入第二个闭合装置似乎是安全有效的。导管心血管介入杂志2004; 63:490-495。 (c)2004年Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号